These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11707650)

  • 1. Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells.
    Funato T; Kozawa K; Kaku M; Sasaki T
    Anticancer Drugs; 2001 Nov; 12(10):829-34. PubMed ID: 11707650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
    Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
    Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells.
    Dong J; Naito M; Tsuruo T
    Oncogene; 1997 Aug; 15(6):639-47. PubMed ID: 9264404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme.
    Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T
    In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenovirus mediated antisense c-myc gene on the chemotherapy sensitivity of osteosarcoma cells to cisplatin].
    Yang DS; Xie XK; Ye ZM; Tao HM
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):799-802. PubMed ID: 16083584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
    Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
    APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
    Stewart DA; Xu X; Thomas SD; Miller DM
    Nucleic Acids Res; 2002 Jun; 30(11):2565-74. PubMed ID: 12034846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.
    Bressin C; Bourgarel-Rey V; Carré M; Pourroy B; Arango D; Braguer D; Barra Y
    Anticancer Drugs; 2006 Feb; 17(2):181-7. PubMed ID: 16428936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC; Hu CP; Chen Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
    Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
    Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inducing apoptosis of HeLa cell lines by transfection of c-myc antisense oligonucleotides].
    Li RR; Ma DX; Cheng YF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):19-22. PubMed ID: 16468633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.